학회지

Sarcopenia is common in lung transplant patients and COVID-19 infection could significantly affect the degree of sarcopenia. In these patients, rehabilitation is important not only for reversal of muscle mass loss, but also for respiratory function. We report of case of 63-year old patient who received lung transplantation due to COVID-19 acute respiratory distress syndrome (ARDS). She was admitted to the intensive care unit (ICU) due to severe COVID-19 pneumonia and met the ICU-acquired weakness (ICU-AW) diagnostic criteria. She underwent pre-habilitation in the intensive care unit before lung transplantation. After surgery, pulmonary rehabilitation was performed with transfer, gait training and resistance exercise. Muscle mass, muscle strength, physical performance, and respiratory function were observed to gradually improve for 1 year after the surgery. However, even after 1 year, the patient is still included in the diagnostic criteria for sarcopenia and complains of functional limitations.